牛叉诊股

[{"date":"2024.11.21","stock":"-0.39","trade":"-0.44","ind":"-0.07"},{"date":"2024.11.20","stock":"4.90","trade":"2.72","ind":"0.78"},{"date":"2024.11.19","stock":"2.30","trade":"2.39","ind":"1.90"},{"date":"2024.11.18","stock":"0.63","trade":"-3.50","ind":"-1.91"},{"date":"2024.11.15","stock":"-2.66","trade":"-3.11","ind":"-2.62"},{"date":"2024.11.14","stock":"-4.31","trade":"-3.97","ind":"-2.83"},{"date":"2024.11.13","stock":"1.39","trade":"-1.49","ind":"0.40"},{"date":"2024.11.12","stock":"0.40","trade":"1.61","ind":"-0.65"},{"date":"2024.11.11","stock":"-0.59","trade":"2.97","ind":"2.03"},{"date":"2024.11.08","stock":"-0.98","trade":"0.47","ind":"-0.66"},{"date":"2024.11.07","stock":"0.99","trade":"2.80","ind":"2.44"},{"date":"2024.11.06","stock":"2.02","trade":"0.63","ind":"-0.35"},{"date":"2024.11.05","stock":"5.10","trade":"3.90","ind":"3.22"},{"date":"2024.11.04","stock":"0.43","trade":"2.62","ind":"1.99"},{"date":"2024.11.01","stock":"-1.26","trade":"-2.50","ind":"-1.28"},{"date":"2024.10.31","stock":"9.95","trade":"0.69","ind":"0.57"},{"date":"2024.10.30","stock":"-2.26","trade":"-2.07","ind":"-0.12"},{"date":"2024.10.29","stock":"3.03","trade":"-2.51","ind":"-1.33"},{"date":"2024.10.28","stock":"4.38","trade":"2.57","ind":"0.62"},{"date":"2024.10.25","stock":"3.27","trade":"4.70","ind":"1.71"},{"date":"2024.10.24","stock":"0.25","trade":"-0.70","ind":"-1.27"}]

美年健康,深证成指,医疗服务指数

压力支撑

该股压力位为5.07元，支撑位为5.00元。

[{"text":"\u538b\u529b\u4f4d","value":"5.07","date":1732118400,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"5.00","date":1732118400,"color":"0x0b52a1"}]

多空趋势

多头行情中，目前处于回落整理阶段且下跌趋势有所减缓。

macd kdj boll asi bias rsi wr vr

资金面诊股

诊断结果：6.0资金面打败了85%的股票主力控盘前10的股票

资金面得分最高的股票

主力控盘

据统计，近10日内主力集中了一定的筹码，呈中度控盘状态。

没有控盘
轻度控盘
中度控盘
高度控盘

行业资金

医疗服务行业，近5日资金总体呈流出状态，请投资者谨慎关注该行业的个股。

更新时间：11月21日 20:30

机构今日流向(万元)	-1048.65	机构5日流向(万元)	-5328.41
机构10日流向(万元)	-14991.37	机构20日流向(万元)	-8125.28

机构持仓

2024-06-30 与 2023-12-31 相比，主力机构持仓量减少31685.6万股，其中基金净增仓26家，主力净减仓130家，暂未发现中长期投资价值。

截止2024-06-30，共191家主力机构（基金183家，一般法人8家），持仓量总计170645.24万股，占流通A股44.07%
其中，基金持仓与2023-12-31相比：
增仓：71家，增持 4852.91万股
减仓：45家，减持 2766.56万股
新出现在主力名单中：57家，持有41542.2万股
从主力名单中消失：187家，原持有75314.15万股

消息面诊股

诊断结果：5.5消息面打败了13%的股票今日有利好新闻的公司

近期该股消息面总体多空平衡，没有较强的利好或利空趋势。

消息面得分最高的股票

消息列表

一般消息	股东大会	临时股东大会	2024-10-16
一般消息	分红转增	不分配不转增	2024-08-30
一般消息	重大事项	公司股东股份解押	2024-07-20
利空	业绩预告	业绩预亏	2024-07-11
一般消息	重大事项	公司股东股份解押	2024-06-08
一般消息	高管变动	因个人职业变动原因	2024-05-16
利好	分红转增	10派0.19元(含税)	2024-04-25
一般消息	高管变动	因工作调整原因	2024-02-26
利好	业绩预告	预计扭亏	2024-01-29
一般消息	重大事项	关联交易	2024-01-24
一般消息	募资投向		2024-01-07
一般消息	资产重组	公司股权转让	2024-01-04
一般消息	高管变动	工作调整原因	2023-12-06

一年消息统计

	所有消息	重大消息	非重大消息
利好	2条	0条	2条
利空	1条	0条	1条

行业面诊股

诊断结果：6.4行业面打败了77%的股票医疗服务行业最新资金流向

近10日来该行业走势不明显，接近大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。

行业面得分最高的股票

行业走势

近10日来该行业走势不明显，接近大盘。

[{"date":"2024.11.21","price":"-0.07","value":"-0.44"},{"date":"2024.11.20","price":"0.78","value":"2.72"},{"date":"2024.11.19","price":"1.90","value":"2.39"},{"date":"2024.11.18","price":"-1.91","value":"-3.50"},{"date":"2024.11.15","price":"-2.62","value":"-3.11"},{"date":"2024.11.14","price":"-2.83","value":"-3.97"},{"date":"2024.11.13","price":"0.40","value":"-1.49"},{"date":"2024.11.12","price":"-0.65","value":"1.61"},{"date":"2024.11.11","price":"2.03","value":"2.97"},{"date":"2024.11.08","price":"-0.66","value":"0.47"},{"date":"2024.11.07","price":"2.44","value":"2.80"},{"date":"2024.11.06","price":"-0.35","value":"0.63"},{"date":"2024.11.05","price":"3.22","value":"3.90"},{"date":"2024.11.04","price":"1.99","value":"2.62"},{"date":"2024.11.01","price":"-1.28","value":"-2.50"},{"date":"2024.10.31","price":"0.57","value":"0.69"},{"date":"2024.10.30","price":"-0.12","value":"-2.07"},{"date":"2024.10.29","price":"-1.33","value":"-2.51"},{"date":"2024.10.28","price":"0.62","value":"2.57"},{"date":"2024.10.25","price":"1.71","value":"4.70"},{"date":"2024.10.24","price":"-1.27","value":"-0.70"}]

深证成指,医疗服务行业

行业排名

排名	股票名称	1月涨跌幅	5日涨跌幅	评分
1	奥浦迈	33.94%	0.02%	5.3分
2	皓宸医疗	31.03%	-12.64%	5.3分
3	毕得医药	30.39%	3.93%	5.1分
4	美年健康	28.64%	4.70%	6.5分
5	普瑞眼科	20.99%	-10.26%	4.9分
6	创新医疗	18.19%	-9.24%	4.8分
7	凯莱英	16.36%	3.24%	5.5分
8	博腾股份	16.11%	-6.05%	3.5分
9	ST中珠	14.29%	-5.88%	4.7分
10	澳洋健康	13.59%	2.52%	5.6分
11	国际医学	12.08%	0.68%	6.0分
12	诺思格	11.26%	-2.23%	5.6分
13	益诺思	10.35%	-2.75%	4.7分
14	和元生物	10.34%	-4.95%	4.6分
15	南模生物	9.90%	-1.37%	4.2分
16	贝瑞基因	9.88%	3.38%	5.8分
17	海特生物	9.50%	-1.47%	4.9分
18	诺禾致源	9.18%	0.97%	5.4分
19	昭衍新药	8.96%	2.11%	4.7分
20	光正眼科	8.79%	-4.75%	5.1分
21	华康医疗	8.75%	1.09%	5.8分
22	新里程	8.66%	-2.13%	4.9分
23	三博脑科	8.15%	-8.55%	4.8分
24	皓元医药	6.64%	-7.50%	4.7分
25	诚达药业	6.15%	-8.92%	4.8分
26	药康生物	6.11%	0.15%	4.9分
27	南华生物	5.39%	1.09%	5.6分
28	何氏眼科	4.65%	-3.28%	4.4分
29	普蕊斯	4.55%	0.87%	6.0分
30	九洲药业	4.47%	0.45%	4.5分
31	爱尔眼科	4.24%	-3.72%	5.0分
32	药明康德	4.05%	-4.10%	4.6分
33	迪安诊断	3.92%	-1.63%	5.0分
34	华厦眼科	3.50%	-4.70%	4.8分
35	美迪西	3.15%	-1.61%	3.9分
36	博济医药	1.54%	-0.22%	5.3分
37	华大基因	1.32%	-2.20%	4.6分
38	阳光诺和	1.30%	-4.83%	5.2分
39	盈康生命	0.50%	-0.39%	5.7分
40	泓博医药	0.31%	-3.34%	5.2分
41	通策医疗	0.18%	-3.59%	4.6分
42	睿智医药	0.15%	-0.15%	5.0分
43	康龙化成	-0.18%	-3.60%	5.6分
44	万邦医药	-0.60%	-0.90%	5.5分
45	金凯生科	-0.65%	1.59%	5.3分
46	兰卫医学	-1.48%	2.01%	5.4分
47	诺泰生物	-1.69%	-0.92%	5.5分
48	成都先导	-2.24%	-8.12%	4.2分
49	药石科技	-2.47%	-3.73%	4.6分
50	泰格医药	-2.74%	0.12%	6.1分
51	百诚医药	-3.58%	-2.44%	5.6分
52	百花医药	-3.86%	-2.30%	4.5分
53	金域医学	-8.37%	-0.66%	5.0分
54	-	-	153.01%	分

<上一页 1 2 3 4 5...9 下一页>

行业评级

最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。

综合评级

研究机构	评级日期	最新评级	上次评级
湘财证券	2012-09-05	中性	-
招商证券	2012-09-05	增持	-
广发证券	2012-09-03	增持	-
中信证券	2012-08-28	增持	-

基本面诊股

诊断结果：6.7基本面打败了76%的股票连续3年业绩增长30%的公司

该公司运营状况良好，多数机构认为该股长期投资价值较高。

个股深一度

潜在高分红能力：弱（30分）

基本面得分最高的股票

[ 截止日期：2024-09-30 ]公司经营

盈利能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 39/96 ， 26/96。

[{"date":"2024-09-30","value":"0.32","vol":"3.45"},{"date":"2024-06-30","value":"-2.85","vol":"2.65"},{"date":"2024-03-31","value":"-3.79","vol":"1.13"},{"date":"2023-12-31","value":"6.67","vol":"4.72"},{"date":"2023-09-30","value":"2.98","vol":"6.22"}]

	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
净资产收益率(%)	0.32	-2.85	-3.79	6.67	2.98
行业(%)	3.45	2.65	1.13	4.72	6.22

该指标值越高，盈利能力越强，行业排名越靠前。

[{"date":"2024-09-30","value":"39.67","vol":"36.79"},{"date":"2024-06-30","value":"35.65","vol":"36.95"},{"date":"2024-03-31","value":"28.04","vol":"36.12"},{"date":"2023-12-31","value":"42.79","vol":"39.51"},{"date":"2023-09-30","value":"39.84","vol":"40.64"}]

	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
销售毛利率(%)	39.67	35.65	28.04	42.79	39.84
行业(%)	36.79	36.95	36.12	39.51	40.64

该指标值越高，盈利能力越强，行业排名越靠前。

成长能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 33/96 ， 42/96。

[{"date":"2024-09-30","value":"-1.96","vol":"2.30"},{"date":"2024-06-30","value":"-5.53","vol":"2.66"},{"date":"2024-03-31","value":"-14.91","vol":"4.69"},{"date":"2023-12-31","value":"26.44","vol":"10.34"},{"date":"2023-09-30","value":"24.81","vol":"9.88"}]

	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
营业收入同比增长率(%)	-1.96	-5.53	-14.91	26.44	24.81
行业(%)	2.30	2.66	4.69	10.34	9.88

该指标值越高，成长能力越强，行业排名越靠前。

[{"date":"2024-09-30","value":"-88.96","vol":"-152.72"},{"date":"2024-06-30","value":"-4228.59","vol":"-97.56"},{"date":"2024-03-31","value":"-66.67","vol":"-46.85"},{"date":"2023-12-31","value":"190.45","vol":"0.01"},{"date":"2023-09-30","value":"158.10","vol":"-386.50"}]

	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
净利润同比增长率(%)	-88.96	-4228.59	-66.67	190.45	158.10
行业(%)	-152.72	-97.56	-46.85	0.01	-386.50

该指标值越高，成长能力越强，行业排名越靠前。

营运能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 18/96 ， 7/96。

[{"date":"2024-09-30","value":"0.37","vol":"0.31"},{"date":"2024-06-30","value":"0.22","vol":"0.20"},{"date":"2024-03-31","value":"0.09","vol":"0.10"},{"date":"2023-12-31","value":"0.58","vol":"0.43"},{"date":"2023-09-30","value":"0.39","vol":"0.32"}]

	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
总资产周转率(次)	0.37	0.22	0.09	0.58	0.39
行业(次)	0.31	0.20	0.10	0.43	0.32

该指标值越高，营运能力越强，行业排名越靠前。

[{"date":"2024-09-30","value":"21.73","vol":"13.99"},{"date":"2024-06-30","value":"13.32","vol":"8.71"},{"date":"2024-03-31","value":"5.86","vol":"4.51"},{"date":"2023-12-31","value":"27.82","vol":"19.08"},{"date":"2023-09-30","value":"20.04","vol":"11.28"}]

	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
存货增长率(次)	21.73	13.32	5.86	27.82	20.04
行业(次)	13.99	8.71	4.51	19.08	11.28

该指标值越高，营运能力越强，行业排名越靠前。

现金流能力：数据暂时不全，请后续关注

[{"date":"2024-09-30","value":"9.85","vol":"12.31"},{"date":"2024-06-30","value":"-2.04","vol":"10.34"},{"date":"2024-03-31","value":"-30.17","vol":"0.77"},{"date":"2023-12-31","value":"50.55","vol":"24.44"},{"date":"2023-09-30","value":"9.84","vol":"16.37"}]

	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
现金流量净额/营业收入	9.85	-2.04	-30.17	50.55	9.84
行业	12.31	10.34	0.77	24.44	16.37

该指标值越高，现金流能力越强，行业排名越靠前。

[{"date":"2024-09-30","value":"","vol":"0.00"},{"date":"2024-06-30","value":"0.34","vol":"1.47"},{"date":"2024-03-31","value":"","vol":"0.00"},{"date":"2023-12-31","value":"0.30","vol":"2.51"},{"date":"2023-09-30","value":"","vol":"0.00"}]

	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
资本支出／折旧和摊销	-	0.34	-	0.30	-
行业	0.00	1.47	0.00	2.51	0.00

该指标值越低，现金流能力越强，行业排名越靠前。

短期偿债能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 25/96 ， 7/96。

[{"date":"2024-09-30","value":"0.75","vol":"4.06"},{"date":"2024-06-30","value":"0.73","vol":"4.09"},{"date":"2024-03-31","value":"0.74","vol":"4.35"},{"date":"2023-12-31","value":"0.79","vol":"4.20"},{"date":"2023-09-30","value":"0.76","vol":"4.21"}]

	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
流动比率	0.75	0.73	0.74	0.79	0.76
行业	4.06	4.09	4.35	4.20	4.21

该指标值越接近2，短期偿债能力越强，行业排名越靠前。

[{"date":"2024-09-30","value":"0.70","vol":"3.34"},{"date":"2024-06-30","value":"0.67","vol":"3.35"},{"date":"2024-03-31","value":"0.67","vol":"3.57"},{"date":"2023-12-31","value":"0.73","vol":"3.49"},{"date":"2023-09-30","value":"0.70","vol":"3.65"}]

	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
速动比率	0.70	0.67	0.67	0.73	0.70
行业	3.34	3.35	3.57	3.49	3.65

该指标值越接近1，短期偿债能力越强，行业排名越靠前。

长期偿债能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 5/96 ， 6/96。

[{"date":"2024-09-30","value":"55.68","vol":"31.14"},{"date":"2024-06-30","value":"56.08","vol":"31.74"},{"date":"2024-03-31","value":"56.19","vol":"31.10"},{"date":"2023-12-31","value":"56.78","vol":"32.13"},{"date":"2023-09-30","value":"54.48","vol":"30.93"}]

	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
资产负债率(%)	55.68	56.08	56.19	56.78	54.48
行业(%)	31.14	31.74	31.10	32.13	30.93

该指标值越接近50%，长期偿债能力越强，行业排名越靠前。

[{"date":"2024-09-30","value":"1.38","vol":"0.84"},{"date":"2024-06-30","value":"1.40","vol":"0.86"},{"date":"2024-03-31","value":"1.40","vol":"0.91"},{"date":"2023-12-31","value":"1.44","vol":"1.05"},{"date":"2023-09-30","value":"1.32","vol":"1.70"}]

	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
产权比率 (%)	1.38	1.40	1.40	1.44	1.32
行业(%)	0.84	0.86	0.91	1.05	1.70

该指标值越高，长期偿债能力越强，行业排名越靠前。

机构评级

最近60个交易日，机构评级以买入为主，认为该股票非常值得关注。

研究机构	评级日期	最新评级	上次评级
海通国际	2024-11-15	增持
海通证券	2024-11-13	增持	增持
财通证券	2024-11-06	增持	增持
东吴证券	2024-11-06	买入	买入
国海证券	2024-11-05	买入	买入
华安证券	2024-11-05	买入	买入

机构预测

机构预测该股2024年每股收益与前一年相同，长期投资价值一般。

[{"date":"2020","yellowRectValue":"5.51","blueLineValue":"","type":""},{"date":"2021","yellowRectValue":"0.64","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"-5.33","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"5.06","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"4.72","blueLineValue":"0.12","type":"YC"}]

[美年健康]

技术面诊股
资金面诊股
消息面诊股
行业面诊股
基本面诊股

【数据基于历史，不代表未来趋势；诊股基于模型与测试，需要投资者根据不同行情合理运用、独立判断、控制风险】

证券咨询服务提供：浙江同花顺云软件有限公司 [编号：zx0050]